LJN Newsletters

This article describes some of the Food and Drug Administration Amendments Act of 2007 provisions related to the expansion of information disclosure and discusses the potential effect of the provisions on product liability exposure.

Product liability litigation sometimes arises when children are injured in and around motor vehicles ' whether it involves a moving or non-moving vehicle. When evaluating responsibility, the acts, omissions, and fault of the caregiver, parent, or person responsible for the child must be considered. In defending this type of litigation, evaluating such responsibility is part of the overall analysis of the design and performance of the motor vehicle and whether having different or additional safety technology would have made a difference or resulted in a different outcome.

What duty, if any, do companies have to police the marketplace and protect consumers against dangers arising from counterfeits? These counterfeits, a number of which are manufactured in China, are generally of a much lower quality and are manufactured without appropriate QA/QC mechanisms that many large companies have in place.

The first installment of this article discussed 'active' reading; understanding the structure of a patent publication; and understanding why certain words were used and others were not. This conclusion addresses how to obtain technical information.

To protect national security, some countries require patent applicants to obtain a foreign filing license prior to filing a patent application abroad. The grant of a foreign filing license provides a governmental stamp of approval that the technology described in the patent application is available for export.

Recent rulings of interest to you and your practice.

Important rulings in neighboring states.

An admission ' an act or declaration of a party or his agent that constitutes evidence against the party at trial ' is an exception to the rule against hearsay. As a general rule, any declaration or conduct of a party or his agent, oral or written, that is inconsistent with that party's position at trial is admissible at trial as an admission.